|Systematic (IUPAC) name|
|Biological half-life||12 hours|
|ATC code||G04CA03 (WHO)|
|Molar mass||387.433 g/mol[[Script error: No such module "String".]]|
Terazosin (marketed as Hytrin) is a selective alpha 1 antagonist used for treatment of symptoms of an enlarged prostate (BPH). It also acts to lower the blood pressure, and is therefore a drug of choice for men with hypertension and prostate enlargement.
Most common side effects include dizziness, drowsiness, headache, constipation, loss of appetite, fatigue, nasal congestion or dry eyes, but they generally go away after only a few days of use. Therapy should always be started with a low dose to avoid first dose phenomenon. Sexual side effects are rare, but may include priapism or erectile dysfunction.
|40px||This antihypertensive-related article is a stub. You can help ssf by expanding it.|
|40px||This drug article relating to the genito-urinary system is a stub. You can help ssf by expanding it.|